Lux Capital's Therapeutics Portfolio

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

H1 is on a mission to connect the world to the right doctor

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.

Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Mahana Therapeutics is a developer of digital treatments for people living with gastrointestinal conditions.

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

NILO Therapeutics is a biotechnology and therapeutics company.

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform